GEN Exclusives

More »

The Lists

More »
Sep 16, 2013

25 Top-Paid Research Institute Leaders

Who in academia is raking it in this year?

25 Top-Paid Research Institute Leaders

This year’s list goes beyond CEOs to include other senior-level executives, such as executive vice presidents, board chairs, and C-suite officers. [© Thomas R. - Fotolia.com]

  • Following is a list of 25 current or former senior executives of independent nonprofit research institutes, ranked by total compensation for the most recent two years such information was available as furnished by Form 990s filed annually by each institution with the Internal Revenue Service and made public through Guidestar.org and Foundation Center. In most cases, the most recent years available were fiscal years ending in 2011 and 2010. In isolated cases, no new Form 990s had been made public since last year.

    Unlike the first edition of this list last year, the percent change in annual pay for each executive was listed. Perhaps reflecting continued pressure on the institutions and other nonprofits to account for executive pay, 10 of the top 25 compensated executives listed either received below-inflation-rate raises, or were paid less than the previous year.

    However, another 10 executives listed saw double- or triple-digit pay raises, some of which included severance or payments from organizations related to the research institutions. In four cases, double- and triple-digit raises followed a promotion or extra responsibilities added on an interim basis.

    Also unlike last year, the list was expanded beyond CEOs to include other senior-level executives, such as executive vice presidents, board chairs, and C-suite officers. The expansion explains why the top 11 highest-paid executives in this year’s list received total pay exceeding $1 million, compared with the top four CEOs in the 2012 list.

    Executives on the list come from 13 research institutions. HHMI alone accounted for eight people, followed by Sanford-Burnham, Stowers, and the J. William Gladstone Institutes (two each), and one each for the other institutions. In some cases the listed chief executives have been succeeded by others; such leadership changes are detailed in footnotes. FY denotes fiscal year; CY denotes calendar year.

  • #25. Leland (Lee) H. Hartwell, Ph.D.1

    Title: President and Director, 1997–20101

    Institution: Fred Hutchinson Cancer Research Center

    FY ending June 30, 2011: $634,1831,2

    FY ending June 30, 2010: $722,0111

    % Change: -12.2%

  • #24. J. Craig Venter, Ph.D.

    Title: Founder, Chairman, and CEO

    Institution: J. Craig Venter Institute

    2011 calendar year: $648,539

    2010 calendar year: $645,929

    % Change: 0.4%

  • #23. Richard Hille

    Title: Former Executive Director3

    Institution: The J. David Gladstone Institutes

    2011 calendar year: $699,6534

    2010 calendar year: $372,153

    % Change: 88.0%

  • #22. Charles Hewett, Ph.D.

    Title: EVP and COO; Interim leader overseeing all administrative, operating, and mouse resources activities and services, 2011–2012

    Institution: The Jackson Laboratory

    Seven months ending December 31, 2011: $719,2735,6

    FY ending May 31, 2011: $599,9945

    % Change: 19.9%

  • #21. Bruce Stillman, Ph.D.

    Title: President

    Institution: Cold Spring Harbor Laboratory

    2011 calendar year: $745,552

    2010 calendar year: $751,839

    % Change: -0.8%

  • #20. Gerald M. Rubin, Ph.D.

    Title: VP and Executive Director, Janelia Farm Research Campus

    Institution: Howard Hughes Medical Institute

    FY ending August 31, 2012: $782,366

    FY ending August 31, 2011: $801,717

    % Change: -2.4%

  • #19. Jack E. Dixon, Ph.D.

    Title: VP and CSO, 2007–20137

    Institution: Howard Hughes Medical Institute

    FY ending August 31, 2012: $808,290

    FY ending August 31, 2011: $794,421

    % Change: 1.7%

  • #18. Eric S. Lander, Ph.D.

    Title: Founding Director and Director of the Genome Biology Program

    Institution: Broad Institute

    FY ending June 30, 2011: $818,876

    FY ending June 30, 2010: $712,468

    % Change: 14.9%



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?